Skip to main content
OTCMKTS:PTEO

Proteo Stock Forecast, Price & News

$0.09
0.00 (0.00 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.09
$0.09
50-Day Range
$0.09
$179.80
52-Week Range
$20.00
$698.00
VolumeN/A
Average Volume11 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PTEO News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteo and its competitors with MarketBeat's FREE daily newsletter.


About Proteo

Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded in 1992 and is based in Irvine, California.

Headlines

Proteo Inc
Proteo Inc
November 30, 2020 |  bloomberg.com
PTEO.PK - Proteo Inc Profile | Reuters
PTEO.PK - Proteo Inc Profile | Reuters
October 4, 2019 |  www.reuters.com
See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PTEO
CUSIPN/A
Phone+1-949-2534616
Employees5
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.52 out of 5 stars

Medical Sector

1545th out of 2,044 stocks

Biotechnology Industry

91st out of 158 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Proteo (OTCMKTS:PTEO) Frequently Asked Questions

What stocks does MarketBeat like better than Proteo?

Wall Street analysts have given Proteo a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Proteo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Proteo's stock been impacted by Coronavirus (COVID-19)?

Proteo's stock was trading at $0.03 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PTEO shares have increased by 199.7% and is now trading at $0.0899.
View which stocks have been most impacted by COVID-19
.

Who are Proteo's key executives?

Proteo's management team includes the following people:
  • Prof. Oliver Wiedow, Pres, CEO, CFO & Director (Age 63)
  • Ms. Birge Bargmann, Chief Exec. Officer of Proteo Biotech AG (Age 60, Pay $25k)
  • Dr. Juergen Michael Paal, Chief Operating Officer of Proteo Biotech AG (Age 49, Pay $36k)
  • Dr. Barbara Kahlke M.D., Ph.D., Sec. (Age 56)

Who are some of Proteo's key competitors?

What other stocks do shareholders of Proteo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proteo investors own include Trigon Metals (TM), ShotSpotter (SSTI), PagSeguro Digital (PAGS), Kaya (KAYS) and Energizer (ENR).

What is Proteo's stock symbol?

Proteo trades on the OTCMKTS under the ticker symbol "PTEO."

How do I buy shares of Proteo?

Shares of PTEO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Proteo's stock price today?

One share of PTEO stock can currently be purchased for approximately $0.09.

How many employees does Proteo have?

Proteo employs 5 workers across the globe.

What is Proteo's official website?

The official website for Proteo is proteo.us.

Where are Proteo's headquarters?

Proteo is headquartered at 2102 Business Center Dr, IRVINE, CA 92612-1001, United States.

How can I contact Proteo?

Proteo's mailing address is 2102 Business Center Dr, IRVINE, CA 92612-1001, United States. The company can be reached via phone at +1-949-2534616.


This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.